Literature DB >> 7370937

Current perspectives in the management of high-grade invasive bladder cancer.

D G Skinner.   

Abstract

Entities:  

Mesh:

Year:  1980        PMID: 7370937

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).

Authors:  P H Smith; J A Child; J H Mulder; A T Van Oosterom; J A Martinez-Pineiro; B Richards; G Stoter; O Dalesio; M De Pauw; R Sylvester
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

2.  Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.

Authors:  I A Korneyev; N N Mamaev; V V Kozlov; M G Rybakova; S H al-Shukri
Journal:  Mol Pathol       Date:  2000-06

Review 3.  Evaluation of 88 cystectomies for bladder cancer.

Authors:  J Kondás; G Diószeghy; E Szentgyörgyi; L Váczi; A Kiss
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

4.  Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes.

Authors:  Cetin Dincel; Cengiz Kara; Ugur Balci; Kutan Ozer; Sait Ozbir; Ertugrul Sefik; Sacit Nuri Gorgel; Cengiz Girgin
Journal:  Int Urol Nephrol       Date:  2013-01-22       Impact factor: 2.370

5.  Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract--a preliminary report.

Authors:  M H Lee; M T Chen; K K Chen; A T Lin; Y H Lee; L M Lee; Y M Chang; L S Chang; J M Liu; R K Hsieh
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 6.  Chemotherapy of advanced transitional-cell carcinoma of the bladder.

Authors:  R S Miller; F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Adjuvant chemotherapy for uroepithelial transitional cell carcinoma.

Authors:  M Kuriyama; T Takeuchi; S Fujihiro; Y Fujimoto; I Shinoda; Y Takahashi; S Yamada; T Nishiura
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

8.  A departmental audit of patients with bladder cancer.

Authors:  R M Sahabudin; R A Persad; F Mishriki; R C Feneley
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

9.  Cost-effectiveness of investigations for invasive bladder cancer.

Authors:  M T Hunt; C R Woodhouse
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.